[1]
“RITUXIMAB VERSUS SPLENECTOMY IN CHRONIC PRIMARY ITP: EXPERIENCE OF A SINGLE HEMATOLOGY CLINIC”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024019, Feb. 2024, doi: 10.4084/MJHID.2024.019.